John Paulson Kamada LTD Transaction History

Paulson & Co. Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$5.39 - $6.26 $4.23 Million - $4.92 Million	-785,525 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.35 - $5.15 $238,053 - $281,833	54,725 Added 7.49%	785,525 $3.73 Million
Q3 2017 Nov 14, 2017	SELL	$4.25 - $4.8 $255,000 - $288,000	-60,000 Reduced 7.59%	730,800 $3.51 Million
Q2 2017 Sep 20, 2017	BUY	N/A	790,800	790,800 $4.75 Million

6.11M

100

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $334M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.